vfa bio represents the field of biotechnology within the vfa

Archive

Zeitraum:
18.04.2007 Cost-Benefit Assessment:
VFA Position Paper "Requirements for a health economic assessment in Germany" mehr
19.02.2007 Pharma research in Germany:
EUR 11 million a day for health research mehr
07.02.2007 Benefits assessment:
Restart required for all ongoing IQWiG procedures mehr
 Printer-friendly copy
Top 

News

Expense forecast:
Increase for medical reasons

G8 summit:
Setting the correct course for combating AIDS in Africa

Cost-Benefit Assessment in Germany:
Orientation by international standards

Publications

Statistics 2009 (English) The pharmaceutical industry in Germany; Facts & Figures
Statistics 2009 (English)
Download PDF Add to basket

All brochures...